KOR

e-Article

A phase 1/2 dose escalation/expansion study of OR2805 alone or in combination in subjects with advanced solid tumors
Document Type
Journal
Source
JOURNAL OF CLINICAL ONCOLOGY; JUN 1 2022, 40 16, 1p. Supplement: S
Subject
Language
English
ISSN
15277755